Wide Range of resources on complex issues
We offer a wide range of resources on complex issues that impact all people with chronic conditions. Resources include member-specific services, frequent meetings and events, publications, and comments on rules and legislation.
Webinar Summary: Real-World Data and Real-World Evidence 101
01/22/2021Webinar Summary: Real-World Data and Real-World Evidence 101 By Sara Gray, Associate, Programs On October 23, the National Health Council (NHC) along with our partners at the
Overview of the End-of-Year COVID Relief and Appropriation Bill
01/20/2021By Madison Mason, Senior Associate, Policy Congress passed the Consolidated Appropriations Act, 2021 on December 21, 2020, which includes $1.4 trillion in funding for the federal government through fiscal
NHC Comments on Proposed 2022 Notice of Benefit and Payment Parameters
01/14/2021By Madison Mason, Senior Associate, Policy On December 30, 2020, the National Health Council (NHC) submitted comments to the Centers for Medicare and Medicaid Services (CMS) on their proposed Notice
Randall L. Rutta Named NHC Chief Executive Officer
01/12/2021Randall L. Rutta Named NHC Chief Executive Officer WASHINGTON, DC, January 12, 2021 – The National Health Council (NHC) Board of Directors has named Randall (Randy)
House of Representatives Health Care Innovation Caucus
01/11/2021On behalf of the National Health Council (NHC), I want to thank you for your leadership of the Health Care Innovation Caucus and your efforts to move
2021 Health Leadership Conference To Bring Executives and Board Members Of Patient Advocacy Organizations Together
01/11/20212021 Health Leadership Conference To Bring Executives and Board Members Of Patient Advocacy Organizations Together By Theo Smith, Associate, Marketing & Communications The National Health
A Blueprint for Effective Health Outreach to Vulnerable Communities: Meeting Patients Where They Are
01/07/2021Guest Contributor: Bansri Desai, PharmD, PhD Candidate in Pharmaceutical Health Services Research, University of Maryland School of Pharmacy In a session entitled, “A Blueprint for Effective Health
Evaluating the Quality of Real-World Evidence
01/06/2021Evaluating the Quality of Real-World Evidence Event Time: 12:00 – 12:45 p.m. ET Event Location: Virtual, Zoom Moderator: Elisabeth Oehrlein, PhD, MS, Assistant Vice President,
The Role of Real-World Evidence in Regulatory Decision-Making
01/04/2021The Role of Real-World Evidence in Regulatory Decision-Making Moderator: Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy and Robert J. Margolis Professor of